Aberrant expression or mutations of Tiam1 has been shown to be associated with a variety of human cancer types including extranodal NK/T-cell lymphoma and chronic lymphocytic leukemia [18, 19]. This evidence concerns the gene TIAM1 and B-cell chronic lymphocytic leukemia.